Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varlitinib plus weekly paclitaxel in EGFR/HER2 co-expressing advanced or metastatic gastric cancer
KCT0003583Phase 2Completed
- Sponsor
- Yonsei University Health System
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varlitinib in gastric cancer (GC), sponsored by Yonsei University Health System. Started Aug 2020; status: completed.
02
Drugs
varlitinib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on KCT0003583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003583.